The fraud-on-the-FDA argument gets another hearing in February in a lawsuit over the Warner-Lambert diabetes drug Rezulin.

FORBES: Can you sue a company for a product the feds approved?

Seven years ago, Rezulin, a Pfizer diabetes drug, was pulled from the market.

FORBES: Magazine Article

But a rival drug, Rezulin, from Pfizer, beat it to market in 1997.

FORBES: Magazine Article

The first PPAR drug, Rezulin from Pfizer, was pulled from the market in 2000 because of liver side effects.

FORBES: Magazine Article

The FDA may have felt pressure to approve Avandia two years later because safety problems were starting to show up with Rezulin.

FORBES: Magazine Article

The first PPAR drug, Rezulin from Pfizer (nyse: PFE - news - people ), was pulled from the market in 2000 because of liver side effects.

FORBES: Open-Source Drug Safety?

The huge number of medicines that turn out to cause liver problems, including withdrawn drugs like Baycol from Bayer or Rezulin from Pfizer, were screened first in cells, then in animals before they were tested in large clinical trails in people.

FORBES: Magazine Article

The long timelines for drug development stem from a large number of factors, but one of the key reasons is that the FDA, largely in response to major drug problems with drugs like Rezulin and the Cox-2 inhibitors, has required larger and longer trials.

FORBES: FDA Wants To Speed Drugs To Market: We've Heard That Before

The huge number of medicines that turn out to cause liver problems, including withdrawn drugs like Baycol from Bayer (nyse: BAY - news - people ) or Rezulin from Pfizer, were screened first in cells, then in animals before they were tested in large clinical trails in people.

FORBES: Cell News Opens Door To Drug Discovery